/

Empresas

Co

No verificado

Cosmos Health Inc.

Sobre qué escribimos

Anuncios brevesBiotecnologíaFinanzasGestión empresarial/Administración de EmpresasMedicina Salud Bienestar

51 Comunicados de prensa

Ver todos los comunicados de prensa

15/06/2026

Biotecnología

Cosmos Health Provides Update on United States Portfolio; Four 18 Series Products Introduced With Projected Annualized Revenue Over $22.7M and Approximately $17.0M Gross Profit

Fuente

Cosmos Health Inc.

Editor

1.00

0

12/06/2026

Biotecnología

Gestión empresarial/Administración de Empresas

Cosmos Health Receives New Contract Manufacturing Orders Totaling 253,657 Units Across a Range of Medicines

Fuente

Cosmos Health Inc.

Editor

1.00

0

12/06/2026

Biotecnología

Cosmos Health Reports Annualized Sales Exceeding $1.5M for Its C-Scrub and C-Sept Antiseptic Brands in the UK and Greece; Plans EU Expansion Targeting $7.4M in Revenue and $5.3M in Gross Profit

Fuente

Cosmos Health Inc.

Editor

1.00

0

11/06/2026

Biotecnología

Cosmos Health Signs LOI to Acquire Doc Pharma S.A., a European GMP Pharmaceutical Manufacturer, a Transformative Step Expected to Boost Assets, Profitability, Production Capacity, and Product Portfolio

Fuente

Cosmos Health Inc.

Editor

1.00

0

11/06/2026

Biotecnología

Finanzas

Cosmos Health Secures Additional 180-Day Nasdaq Extension to Regain Bid Price Compliance

Fuente

Cosmos Health Inc.

Editor

1.00

0

10/06/2026

Biotecnología

Gestión empresarial/Administración de Empresas

Cosmos Health Signs 3-Year Contract Manufacturing Agreement with Verisfield for 3.9 Million Units of VASCLOR GEST Progesterone Pessaries

Fuente

Cosmos Health Inc.

Editor

1.00

0

10/06/2026

Biotecnología

Finanzas

Medicina Salud Bienestar

Cosmos Health CEO Issues Letter to Shareholders: Building an Innovative AI-Driven Global Healthcare Platform — Record Growth with U.S. Expansion Underway

Fuente

Cosmos Health Inc.

Editor

1.00

0

09/06/2026

Biotecnología

Anuncios breves

Cosmos Health Inaugurates State-of-the-Art Capsule Production Line with New 5-Year Contract Manufacturing Agreement with Provident Pharmaceuticals for 385,000 Units of CERTORUN

Fuente

Cosmos Health Inc.

Editor

1.00

0

08/06/2026

Biotecnología

Anuncios breves

Cosmos Health Completes Acquisition of Strategic Intellectual Property and Expands Nanotechnology Investment Initiatives

Fuente

Cosmos Health Inc.

Editor

1.00

0

05/06/2026

Biotecnología

Medicina Salud Bienestar

Anuncios breves

Cosmos Health Continues U.S. Expansion with Launch of Oliv18, Targeting Cardiovascular and Antioxidant Categories

Fuente

Cosmos Health Inc.

Editor

1.00

0

Seguidores

0

Compatibilidad

0